MSN Labs Secures SEC Nod for Phase III Trial of Vibegron 75 mg, Excluding Refractory OAB Patients
- 02 November 2025
- 23 hours ago
MSN Labs Gets SEC Go-Ahead to Conduct Phase IV Clinical Trial on Elagolix for Endometriosis
- 01 November 2025
- 1 day ago
Boehringer Ingelheim Told to File Separate Phase IV Trial Plan for Empagliflozin
- 01 November 2025
- 1 day ago
Nearly 50% of Drug Inspector Posts Vacant at CDSCO, Reveals RTI Response
- 01 November 2025
- 1 day ago
Zydus Lifesciences Told To Revise PMS Study For Tofacitinib ER Tablets
- 30 October 2025
- 3 days ago
MP FDA Moves Rs 320-Crore Proposal to CDSCO, FSSAI to Upgrade Drug, Food Testing Labs
- 29 October 2025
- 4 days ago
Maha: Rs 14-Crore Mephedrone Unit Busted Near Police Station, Cop Suspended for Negligence
- 29 October 2025
- 4 days ago
Recent News
GLP-1 Receptor Agonists Linked to Lower Risk of Ea...
- 03 November, 2025
Ketogenic diet may protect against stress experien...
- 03 November, 2025
STORM-PE Trial: Mechanical Thrombectomy Shows Supe...
- 03 November, 2025
AIIMS INI CET January 2026 admit cards released
- 03 November, 2025
3 pharma students drown in Payyambalam beach in Ke...
- 03 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.









